-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Human immunodeficiency Virus (HIV)
CAS No. | Product Name | Inquiry |
---|---|---|
2757182-99-1 |
HIV-1-inhibitor-15HIV-1 inhibitor-15 (compound 9d) is a highly potent and broad-spectrum HIV-1 inhibitor. HIV-1 inhibitor-15 has inhibitory activity against HIV-1 WT, L100I, K103N, Y181C, E138K with EC50s of 1.7 nM, 4 nM, 2 nM, 6 nM and 9 nM, respectively. HIV-1 inhibitor-15 has good solubility, safety profiles and favorable oral bioavailability. |
|
2758387-58-3 |
HIV-1-inhibitor-20HIV-1 inhibitor-20 is a potent HIV-1 inhibitor by non-classical isosteric replacement of amide to 1,2,4-oxadiazoles. |
|
2761009-30-5 |
CXCR4 antagonist 4 |
|
2761172-60-3 |
HIV-1 inhibitor-13 |
|
2761172-65-8 |
HIV-1 inhibitor-14 |
|
2762302-75-8 |
DENV-IN-4DENV-IN-4 is a specific inhibitor targeting the Dengue virus (DENV), specifically the serotype 4. Dengue fever is caused by four different serotypes of the virus (DENV-1 to DENV-4), and researchers develop inhibitors and vaccines to combat each serotype. DENV-IN-4 would be a compound or drug designed to inhibit the activity of the Dengue virus serotype 4, potentially by interfering with the virus's ability to replicate or bind to host cells. These inhibitors are crucial for developing treatments and vaccines against dengue fever, especially in regions where the virus is endemic. |
|
2762922-66-5 |
HIV-1 inhibitor-71 |
|
2764787-56-4 |
HIV-1 inhibitor-18 |
|
2764787-76-8 |
HIV-1 inhibitor-17 |
|
2765293-30-7 |
HIV-1-protease-IN-1HIV-1 protease-IN-1 (Compound 1e) is a potent inhibitor of HIV-1 protease with an IC50 of 90 pM. HIV-1 protease-IN-1 demonstrates antiviral activity with EC50 value of 89 nM against B-HIV. HIV-1 protease-IN-1 exhibits activity with EC50 value of 13.59 nM against C-HIV strain ZM246. HIV-1 protease-IN-1 shows remarkable activity with EC50 value of 8.23 nM against HIV strain Indie. |
|
2771211-71-1 |
HIV-1 inhibitor-54 |
|
2771211-73-3 |
HIV-1 inhibitor-55 |
|
2772702-10-8 |
Peldesine dihydrochloride |
|
27740-01-8 |
ScutellarinScutellarin has been shown to induce apoptosis of ovarian and breast tumor cells in vitro. |
|
2789676-44-2 |
HIV-1 inhibitor-40 |
|
280138-71-8 |
DAPD-NHc-pr |
|
2801703-79-5 |
HIV-1 inhibitor-72 |
|
280571-30-4 |
S 1360 |
|
28230-32-2 |
HODHBtHOOBt is a STAT5-SUMO protein-protein interaction inhibitor that suppresses SUMOylation of phosphorylated STAT5. |
|
2825-00-5 |
AureothinAureothin is produced by the strain of Streptomyces thioluteus 4-A-1 and Streptomyces sp. 58. An unusual pyranone metabolite; has broad biological actions including antitumour, antimicrobial and insecticidal activities; a potent inhibitor of helicobacter pylori. |
※ Please kindly note that our services are for research use only.